Target intelligence / Profile preview

Mast/stem cell growth factor receptor Kit (KIT)

Target
KIT
Molecular classification
Receptor tyrosine kinase, Type III receptor tyrosine kinase, Enzyme, Receptor
01

Overview

The c-Kit/SCF signaling axis is a critical pathway for the development and maintenance of various cell lineages, including hematopoietic stem cells, mast cells, melanocytes, and germ cells. The axis is activated when the ligand, Stem Cell Factor (SCF), binds to the extracellular domain of the c-Kit receptor (CD117), a type III receptor tyrosine kinase, leading to receptor dimerization, autophosphorylation, and activation of downstream signaling cascades like PI3K/AKT, MAPK/ERK, and JAK/STAT. Dysregulation of this axis, often through gain-of-function mutations in the KIT gene, is a primary driver in several malignancies, most notably gastrointestinal stromal tumors (GIST) and systemic mastocytosis. Consequently, c-Kit has become a major therapeutic target for small-molecule tyrosine kinase inhibitors (TKIs). While these drugs have revolutionized treatment for KIT-driven cancers, the emergence of secondary resistance mutations remains a significant clinical challenge. Therapeutic strategies now focus on next-generation inhibitors capable of overcoming these resistant variants.

Other names
c-KitCD117PBTSCFRMast/stem cell growth factor receptorProto-oncogene c-KitTyrosine-protein kinase KIT
02

Mechanism of action

Small molecule inhibition of the intracellular tyrosine kinase domain, preventing autophosphorylation and downstream signaling cascades.

03

Biological functions

Signal transductionCell proliferationCell survivalHematopoiesisMelanogenesisGametogenesisMast cell development
04

Disease associations

Gastrointestinal stromal tumorSystemic mastocytosisAcute myeloid leukemiaMelanomaPiebaldism
05

Safety considerations

MyelosuppressionCardiotoxicityHepatotoxicityGastrointestinal perforationFluid retention and edemaSkin and hair depigmentation
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

KIT mutation status (e.g., Exon 9, 11, 13, 17)CD117 protein expression (IHC)Serum tryptase levels

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Mast/stem cell growth factor receptor Kit (KIT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mast/stem cell growth factor receptor Kit (KIT).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call